Valeo Pharma Inc
F:VP2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valeo Pharma Inc
F:VP2
|
CA |
|
Zumtobel Group AG
F:T9Z
|
AT |
|
RENERGEN Ltd
F:996
|
ZA |
|
J
|
JAFCO Group Co Ltd
DUS:JAF
|
JP |
|
K
|
Kirin Holdings Co Ltd
XMUN:KIR
|
JP |
|
C
|
Carlisle Companies Inc
DUS:CLE
|
US |
|
Fabasoft AG
OTC:FBSFF
|
AT |
|
E
|
Entain PLC
F:6GI
|
IM |
|
E
|
Entain PLC
F:6GI0
|
IM |
|
dentalcorp Holdings Ltd
F:6A7
|
CA |
|
Rakuten Group Inc
F:RAK
|
JP |
|
G
|
Gruppo MutuiOnline SpA
MIL:MOL
|
IT |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
C
|
Coface SA
F:65C
|
FR |
|
R
|
Ramelius Resources Ltd
F:RRZ
|
AU |
|
P
|
Pulmatrix Inc
F:2PU1
|
US |
|
K
|
Kitwave Group PLC
LSE:KITW
|
UK |
|
Kanabo Group PLC
F:3WD
|
UK |
|
R
|
Ramelius Resources Ltd
XMUN:RRZ
|
AU |
|
G
|
Galp Energia SGPS SA
DUS:GZ5
|
PT |
|
D
|
Daito Trust Construction Co Ltd
SWB:4D7
|
JP |
|
L
|
Lenovo Group Ltd
OTC:LNVGF
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VP2's stock price target?
Not Available
VP2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Valeo Pharma Inc?
Projected CAGR
14%
Over the last 6 years, the compound annual growth rate for Revenue has been 87%. The projected CAGR for the next 2 years is 14%.